BofA lowered the firm’s price target on AMN Healthcare (AMN) to $18 from $20 and keeps an Underperform rating on the shares. While hospital fundamentals should remain solid in the second half, the firm is concerned that the policy and reimbursement environment will be more negative compared to recent years, says the analyst, who prefers post-acute over hospitals as the least exposed to the upcoming cuts given this backdrop. The firm is updating estimates and price targets for several companies in its health care facilities coverage.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMN:
- AMN Healthcare price target lowered to $22 from $33 at Citizens JMP
- AMN Healthcare’s Mixed Earnings Call: Strong Performance Amid Challenges
- AMN Healthcare price target lowered to $22 from $27 at BMO Capital
- AMN Healthcare Services: Hold Rating Maintained Amid Weaker Demand and Uncertain Recovery
- AMN Healthcare Reports Q2 2025 Financial Results